Schering OTC Claritin Launch May Await Loratadine Patent Dispute Resolution
This article was originally published in The Tan Sheet
Executive Summary
Schering-Plough could be considering delaying the OTC launch of Claritin pending resolution of its underlying patent litigation for the drug